TEM Tempus AI, Inc.
$59.01▲ +0.46%
Healthcare
Other
After hours
$59.05▲ +0.07%
Sep 11, 7:58 PM ET
Volume 3.67M
Avg Volume (10D) 6.13M
Key Metrics & Fundamentals
Market Cap
$10.65B
P/E Ratio
–
Div Yield
–%
52W Range
40.77 - 104.32
% vs 50 MA
5.61%
% vs 200 MA
4.87%
RSI-14
48.3
MACD Histogram
-1.1000
Beta (1Y vs SPY)
2.53
Free Cash Flow
-$18.62M
Gross Rev
$382.49M
Gross Profit
$246.50M
EBITDA
$56.73M
COGS
$135.99M
Operating Exp
$322.41M
Operating Income
-$75.91M
EBIT
-$75.91M
Pretax Income
$8.82M
Net Income
$5.64M
EPS (Diluted)
0.03
Price & Volume History
Loading chart…
Recent News
Tempus AI Building Multimodal Whole-Genome Dataset for AI Research
MT Newswires · Sep 11, 2026 1:02 PM

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation
Business Wire · Sep 11, 2026 12:30 PM
Tempus AI Secures Up To $9.5 Million in US Agency Funding for Cardiology Agent
MT Newswires · Sep 9, 2026 8:32 PM

Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology
Business Wire · Sep 9, 2026 8:01 PM

Cathie Wood Grows Robinhood Stake; Sheds More AMD, Palantir
Investor's Business Daily · Sep 9, 2026 1:06 PM
UBS Initiates Coverage on Tempus AI With Neutral Rating, $70 Price Target
MT Newswires · Sep 9, 2026 12:17 PM
Rothschild & Co Redburn Initiates Tempus AI at Neutral With $67 Price Target
MT Newswires · Sep 8, 2026 10:12 AM

The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI
BeInCrypto · Sep 8, 2026 1:49 AM

Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Business Wire · Sep 4, 2026 12:30 PM

The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels.
The Wall Street Journal · Sep 4, 2026 9:30 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See TEM's money flow as a full page
Social Sentiment
Avg +0.70 · 65 posts
NewsDiscussionTradePriceTargetI’ve been keeping an eye on TEM lately. Could this be a growth stock in the AI healthcare sector?
r/stocks · Jun 28, 2026
The post discusses TEM's revenue growth, price action, and potential as a growth stock in the AI healthcare sector, indicating a positive outlook.
positive
+0.60
DDNewsTradeDiscussionWhy Tempus AI is perfectly positioned to squeeze Wall Street out of their own position.
r/StockMarket · Jun 6, 2026
The post analyzes the convertible notes offering, framing it positively for the stock's potential future.
positive
+0.70
TradeDiscussionThe next AI rotation - from infrastructure to data reservoirs
r/wallstreetbets · May 28, 2026
References TEM in the context of the AI supercycle and its potential as a data platform.
positive
+0.60
DDTradeEarningsPriceTargetMissed the Chips/Memory rally? Buy the DNA: $TEM
r/wallstreetbets · May 8, 2026
Strong buy recommendation with optimistic projections and details on the company's business model.
very_positive
+1.00
TradeDiscussionPMCC strategy: stocks and comments
r/options · Apr 14, 2026
Positively highlighted as a decent pick and referenced in relation to volatility benefits.
positive
+0.60
Page 1 of 13 (65 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.